Clinical Trial Update: The Effects of Z-338 in Subjects With and Without Functional Dyspepsia [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial evaluating Z-338 in subjects with and without functional dyspepsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• Z-338

Snippet

Sponsor: Zeria Pharmaceutical | Conditions: Dyspepsia | Phase 2 | Status: COMPLETED